Raynaud's Syndrome - Biotech, Pharma and Life Science Channel

22:20 EDT 22nd October 2014 | BioPortfolio

PubMed Articles [5329 Associated PubMed Articles listed on BioPortfolio]

Dual Antiplatelet Therapy in the Anticoagulated Patient Undergoing Percutaneous Coronary Intervention Risks, Benefits, and Unanswered Questions.

A commonly encountered scenario is the patient with atrial fibrillation (AF) on oral anticoagulation (OAC) who either develops an acute coronary syndrome or has to undergo percutaneous coronary interv...

Use of Left Ventricular Support Devices During Acute Coronary Syndrome and Percutaneous Coronary Intervention.

In an effort to improve outcomes in percutaneous coronary intervention (PCI), percutaneous ventricular assist devices (PVADs) have been investigated in (1) high-risk PCI, (2) acute myocardial infarcti...

Editorial: abnormal permeability and altered mucosal serotonin metabolism in the irritable bowel syndrome - is there a link?

Obesity, Metabolic Syndrome, and Airway Disease: A Bioenergetic Problem?

Multiple studies have determined that obesity increases asthma risk or severity. Metabolic changes of obesity, such as diabetes or insulin resistance, are associated with asthma and poorer lung functi...

Total Local Anesthetic Administered Is Integral to the Syndrome of Local Anesthetic Systemic Toxicity.

Impact of childhood obesity on cardiac structure and function.

Obesity prevalence is still on the rise worldwide in both adults and children. In adults, obesity is a significant cardiovascular risk factor associated with increased morbidity and mortality. In chil...

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies.

Since the original publication describing the illness in 1907, the genetic understanding of Alzheimer's disease (AD) has advanced such that it is now clear that it is a genetically heterogeneous condi...

Judicious use of biologicals in juvenile idiopathic arthritis.

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disorder that may cause joint destruction. Biological treatments targeting specific cytokines and cell interactions have transformed the o...

Prognostic utility of the soluble CD40 ligand in acute coronary syndrome.

Ulcerative colitis and Budd-Chiari syndrome: which comes first?

News Articles [1491 Associated News Articles listed on BioPortfolio]

DXA-measured visceral adipose tissue predicts impaired glucose tolerance and metabolic syndrome in obese Caucasian and African-American women

GW Pharmaceuticals granted orphan designation by the EMA for Epidiolex

Cannabinoid product specialist GW Pharmaceuticals has been granted orphan designation by the European Medicines Agency for its investigational product Epidiolex (cannabidiol) in the treatment of Drave...

IBS Yields to Rifaximin -- Repeatedly

(MedPage Today) -- Antibiotic works in first-time and relapsed diarrhea-predominant irritable bowel syndrome.

Glaucoma Foundation Holds Third Scientific Think Tank On Exfoliation Syndrome

NEW YORK, Oct. 22, 2014 /PRNewswire-USNewswire/ -- The Glaucoma Foundation's recently concluded 2014 International Scientific Think Tank was TGF's third consecutive annual gathering to focus...

Ipsen to commercialize Lexicon carcinoid drug ex-North America/Japan

French drugmaker Ipsen has entered into an accord with Lexicon Pharmaceuticals to commercialize the US drug developer’s telotristat etiprate outside of North America and Japan, with a focus on the t...

Immune Pharma funds study supporting bertilimumab use in irritable bowel syndrome

US-Israeli Immune Pharmaceuticals has funded a study yielding clinical data to demonstrate the importance of intestinal-eotaxin-1-Eosinophil axis in inflammatory bowel disease.

Innocrin Pharmaceuticals Created as a Spin-out of the Prostate Cancer Program from Viamet Pharmaceuticals

Will Focus on Clinical Development of Best in Class Dual CYP17 Lyase Inhibitor / Androgen Receptor (AR) Antagonist Innocrin Pharmaceuticals, Inc., (www.innocrinpharma.com), ...

Expert recommendations for diagnosing pediatric acute onset neuropsychiatric syndrome

A panel of leading clinicians and researchers across various general and specialty pediatric fields developed a consensus statement recommending how to evaluate youngsters in whom neuropsychiatric sym...

Genetics: Telomere length and the metabolic syndrome—a causal link?

Shortening of leukocyte telomeres is considered a molecular marker for ageing and is suggested to be linked with increased risk of cardiovascular and metabolic disease. A large population-based study ...

BRIEF-GW Pharma childhood epilepsy drug gets orphan designation from EMA

* Epidiolex receives orphan designation from European Medicines Agency for treatment of Dravet Syndrome

Events [0 Results]

None

Companies [46 Associated Companies listed on BioPortfolio]

Innocrin Pharmaceuticals, Inc.

Innocrin discovers and develops novel, best-in-class oral inhibitors of CYP17 lyase, a validated enzyme target for the treatment of castration-resistant prostate cancer. VT-464 an...

Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical...

Sea-licious™

Karlene Karst, a Registered Dietician, is a leading health specialist in both nutrition and natural medicine. She is the co-author of the national best seller “Healthy ...

Synergy Pharmaceuticals Inc.

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of new drugs to treat patients with gastrointestinal (GI) diseases and disorders. Synergyâ...

Sturge-Weber Foundation

Since its founding in 1987, the Sturge-Weber Foundation (SWF) has provided information, education and friendly support to adults and families of children with Sturge-Weber syndrom...

Horizon Science

Horizon Science is an Australian-based company that develops natural innovative sugar cane molasses extracts enriched with polyphenols for health benefits in blood glucose managem...

Nathealth Solutions

Nathealth Solutions is the U.S.-based distributor of BergaMet MEGA, the most powerful, natural agent for the management of lipid disorders. Derived from the Citrus bergamia Risso ...

Ironwood Pharmaceuticals, Inc. and Bionomics Limited

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwood’s GC-C agonis...

Shionogi & Co., Ltd.

Headquartered in Osaka, Japan, Shionogi & Co., Ltd. is a major research-driven pharmaceutical company dedicated to placing the highest value on patients. Shionogi’s Research ...

Akebia Therapeutics, Inc.

Akebia Therapeutics is a discovery and development company focused on anemia and vascular disorders. Akebia’s lead program, AKB-6548, an orally bioavailable HIF-prolyl hydrox...

Clinical Trials [1842 Associated Clinical Trials listed on BioPortfolio]

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

This study investigates gene abnormalities in Primary Immune Deficiency(PID) with a goal of improving the diagnosis and treatment of patients. The specific disorders include: 1....

Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

This phase I trial studies the side effects and best dose of ipilimumab in treating patients with high-risk myelodysplastic syndrome or acute myeloid leukemia that has come back or no long...

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

From 1999, several studies have showed that the use of vasoconstrictors in association with albumin are effective in the treatment of hepatorenal syndrome (HRS). The rationale of the use o...

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

This double-blind, randomized, placebo-controlled, multi-center study will evalu ate the safety and efficacy of dalcetrapib in patients hospitalized for an acute coronary syndrome (ACS). T...

Tocilizumab for the Treatment of Behcet's Syndrome

This is a double-blind placebo controlled study targeting individuals with active Behcet's Syndrome who have oral ulcers and are resistant (have not responded after 4 weeks) to conventiona...

Fructose and Fructans in IBS

The purpose of the study is to investigate if patients with Irritable Bowel Syndrome (IBS) who also report bloating are more likely to report clinically important gastrointestinal symptoms...

Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

The purpose of this study is to determine if vitamin D will improve insulin resistance, inflammation, and overall well-being in women with PCOS.

Efficacy of Minoxidil in Children With Williams-Beuren Syndrome

The Williams-Beuren syndrome (WBS) is a sporadic congenital disorder characterized by a multisystem developmental impairment. This syndrome is caused by a microdeletion in chromosome 7q11....

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients

Cumberland Pharmaceuticals Inc. (CPI) is developing ifetroban for treatment of hepatorenal syndrome (HRS) and proposes to conduct a study in hospitalized adult patients with HRS to assess...

NIV Strategies for RDS in Preterm Infants. NIV (Non Invasive Ventilation), RDS (Respiratory Distress Syndrome)

The purpose of this study is to determine whether two different strategies of Non Invasive Ventilation (NIV) have different effect on length and failure of NIV support in preterm infants w...

Medical and Biotech [MESH] Definitions

An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

A mild form of LIMITED SCLERODERMA, a multi-system disorder. Its features include symptoms of CALCINOSIS; RAYNAUD DISEASE; ESOPHAGEAL MOTILITY DISORDERS; sclerodactyly, and TELANGIECTASIS. When the defect in esophageal function is not prominent, it is known as CRST syndrome.

A selective adrenergic alpha-1 antagonist used in the treatment of heart failure, hypertension, pheochromocytoma, Raynaud's syndrome, prostatic hypertrophy, and urinary retention.

A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease.

A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Raynaud's Syndrome market research data and corporate reports here

Channels Quicklinks